Prospective
Diagnostic TestBlood samples will be collected in order to meet the objectives of this substudy and possibly for complementary research
NCT Number: NCT06913959
The aim of the study is to study the genotypic characteristics of HIV-1 non-M circulating in the whole Cameroon and their genetic evolution.
Trial opening soon.
Get Notified21 year and older
All sexes
Observational
HIV-1 is divided four distinct groups: M (major) which represents the pandemic strains while others groups O (outlier), N (non M, non O) and P are called non-M variants. Group O (HIV-O) is more divergent, endemic in Central Africa and Cameroon, where it represents about 1% of HIV infections. These variants are characterized by an important genetic divergence from pandemic HIV-1 group M (HIV-M), which impacts on the diagnosis, monitoring and treatment of infected patients. Although discovered in 1990, and emerged at the same time as HIV-M, no data of epidemiology, natural history and evolution of the genetic diversity of these variants is currently available. The few knowledge available to date come from sporadic cases, mainly through studies in Yaoundé. It is therefore essential to improve current knowledge on these variants and their consequences on infected patients.
The aim of the study is to study the genotypic characteristics of HIV-1 non-M circulating in the whole Cameroon and their genetic evolution.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Blood samples will be collected in order to meet the objectives of this substudy and possibly for complementary research
Time frame: 1 day
Number of participants infected with non-M HIV-1 included compared to the total expected number of inclusions
Time frame: 1 Day
Proportion of non-M HIV-1 samples characterized genotypically among the samples collected from participants included in the project
Time frame: 1 day
Proportion of non-M HIV-1 samples characterized for resistance among the samples collected from participants included in the project
Contact information is provided by the study sponsor or research team.
Elodie Alessandri-Gradt, ParmD PhD
CONTACT
Mariam Gharib, PhD
CONTACT
ANRS, Emerging Infectious Diseases
Other Gov
Acronym: OBSOCAM
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07209267
Blood-Borne Infections, Communicable Diseases
Atlanta, Georgia, United States
View Trial DetailsNCT07695493
Blood-Borne Infections, Communicable Diseases
View Trial DetailsNCT07620652
Blood-Borne Infections, Communicable Diseases
Modena, MO, Italy
View Trial DetailsNCT07681908
Behavior, Blood-Borne Infections
San Clemente, California, United States
View Trial Details